Photodynamic therapy for polypoidal choroidal vasculopathy
详细信息 查看全文
- 作者：Patrycja Nowak-Sliwinska ; Hubert van den Bergh ; Michel Sickenberg ; Adrian H.C. Koh
- 关键词：Age-related macular degeneration ; Anti-Angiogenesis ; Choroidal neovascularization ; Optical coherence tomography ; Polypoidal choroidal vasculopathy ; Visudyne® ; -photodynamic therapy
- 刊名：Progress in Retinal and Eye Research
- 出版年：November, 2013
- 年：2013
- 卷：37
- 期：Complete
- 页码：182-199
- 全文大小：1970 K
文摘
The first effective therapy for exudative macular degeneration (AMD) was Photodynamic Therapy (PDT). Diagnosis of the disease was to a large extent by fluorescein angiography (FA). Distinguishing between the leaky choroidal neovessels (CNV) associated with exudative AMD, and the polypoidal structures associated with Polypoidal Choroidal Vasculopathy (PCV) is not always easy using FA alone. The switch to Indocyanine Green angiography helped to pinpoint PCV, and thus to study the efficacy of photodynamic therapy of this particular form of retinal disease, which is more frequently encountered among pigmented individuals. The results appear to be quite promising, and in the year following treatment only a small fraction of the patients had to be retreated. Alternatively, treating PCV with repeated intravitreal VEGF blocking agents was not as successful as it was in the treatment of wet AMD. However, combining PDT-induced angio-occlusion of the polypoidal lesions with anti-vascular endothelial growth factor therapy was shown to be quite effective, and the combination of PDT with an anti-angiogenic agent as well as a steroid, in a triple therapy, was recently also shown to be a quite promising option. In the present article we review the data on PDT of PCV, including combination therapies and alternative treatments. We also report on similarities and differences between AMD and PCV.